Exagen Inc. (NASDAQ: XGN)
$5.0000
-0.0200 ( -1.96% ) 65.8K
Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.
Market Data
Open
$5.0000
Previous close
$5.0200
Volume
65.8K
Market cap
$88.54M
Day range
$4.7480 - $5.2200
52 week range
$1.3003 - $6.2200
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 15 | May 13, 2024 |
ars | Annual reports | 1 | Apr 26, 2024 |
8-k | 8K-related | 14 | Apr 26, 2024 |
def | Proxies and info statements | 4 | Apr 26, 2024 |
10-k | Annual reports | 82 | Mar 18, 2024 |
8-k | 8K-related | 15 | Mar 18, 2024 |
4 | Insider transactions | 1 | Mar 06, 2024 |
4 | Insider transactions | 1 | Mar 04, 2024 |
4 | Insider transactions | 1 | Feb 22, 2024 |
4 | Insider transactions | 1 | Feb 22, 2024 |